Pro Medicus Ltd
ASX:PME
Pro Medicus Ltd
ASX:PME
Price:
111.41 AUD
-0.21%
Market Closed
Updated:
Apr 30, 2024
P/B
Price to Book Value
Price to Book Value
73.1
Current
59
Median
2.2
Industry
Higher
than median
Higher
than industry value
Price to Book Value (P/B) ratio is a valuation multiple that measures the market's valuation of a company relative to its book value. The P/B ratio is only considered useful in practice when applied to capital-intensive businesses.
P/B
=73.1
Market Cap
/
11.6B
Book Value of Equity
159.2m
All Countries
| Market Cap | P/B | ||||
|---|---|---|---|---|---|
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.6B AUD | 73.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.5B USD | 7 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 7.1 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.7 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 3.5 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7.2B USD | 12.6 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.5B USD | 5.2 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.2B SEK | 30.4 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 2.5 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.7 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 17 |
P/B Forward Multiples
Forward P/B multiple is a version of the P/B ratio that uses forecasted equity for the P/B calculation. 1-Year, 2-Years, and 3-Years forwards use equity forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/B
N/A
2-Years Forward
P/B
N/A
3-Years Forward
P/B
N/A
You don't have any saved screeners yet
